Evidence map›Paper›PMID 40588622›Full record

ArticleInternational journal of impotence research2026

Measuring the perceived duration of post-ejaculatory penile detumescence: a pilot study in a real-life setting.

Chris A Suijker, Janniko R Georgiadis, Boaz Meijer

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chris A SuijkerUniversity of Groningen, University Medical Center Groningen, Department of Urology, Groningen, The Netherlands. c.a.suijker@umcg.nl.ORCID http://orcid.org/0000-0003-0715-2376
Janniko R GeorgiadisUniversity of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Section Anatomy & Medical Physiology, Groningen, The Netherlands.
Boaz MeijerDepartment of Urology, ACIBADEM International Medical Center, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penile detumescence is crucial for erectile physiology and may play a role in erectile dysfunction and priapism. However, few studies focus on the process of penile detumescence. This pilot study explores the feasibility of measuring the perceived duration of post-ejaculatory penile detumescence in real-life conditions in a convenience sample. Voluntary participants could access a survey between November 2020 and February 2021, with measurement instructions shared by the researchers across several online social networks. Participants measured penile detumescence, starting a stopwatch at ejaculation and recording two time points: onset of flaccidity and complete flaccidity. The survey collected basic demographics for description purposes. At survey closure, full responses of 83 (mean age 26.9 ± 8.9 years) participants were analyzed. The mean duration to onset of flaccidity was 57.9 ± 35.5 s, and to complete flaccidity was 180.7 ± 83.5 s, both following an approximately normal distribution. These durations were significantly correlated with each other (r = 0.47, p < 0.001), but not with any other variables. The results suggest that quantifying penile detumescence in real-life conditions is feasible. Future studies with a more robust design should verify these measurements and explore factors influencing detumescence duration in both real-life conditions and research settings.

Indexed as

EjaculationErectile DysfunctionPenile ErectionPenisAdultFeasibility StudiesHumansMalePilot ProjectsSurveys and QuestionnairesTime FactorsYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.